Who Buys Enoxaparin from India — 505 Importers Behind a $209.4M Market
India's enoxaparin import market is served by 505 active buyers who collectively imported $209.4M across 3,309 shipments. FRESENIUS KABI USA, LLC (UNITED STATES) leads with a 23.2% market share, followed by BOSTON ONCOLOGY ARABIA and BE PHARMACEUTICALS INC. The top 5 buyers together control 63.6% of total import value, reflecting a concentrated buyer landscape.
Top Enoxaparin Importers — Ranked by Import Value
FRESENIUS KABI USA, LLC (UNITED STATES) is the leading enoxaparin importer from India, holding a 23.2% share of the $209.4M market across 3,309 shipments from 505 buyers. The top 5 buyers — FRESENIUS KABI USA, LLC (UNITED STATES), BOSTON ONCOLOGY ARABIA (SAUDI ARABIA), BE PHARMACEUTICALS INC (UNITED STATES), FRESENIUS KABI USA LLC (UNITED STATES), EVERSANA (UNITED STATES) — collectively control 63.6% of total import value.
Top Enoxaparin Buyers & Importers
Ranked by import value · 505 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI USA, LLCUNITED STATES ENOXAPARIN SODIUM INJECTION USP 40MG/0.4MLENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGES51000441 - ENOXAPARIN SODIUM INJECTION, | $48.6M | 5 | 23.2% |
| 2 | BOSTON ONCOLOGY ARABIASAUDI ARABIA LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN | $44.5M | 5 | 21.3% |
| 3 | BE PHARMACEUTICALS INCUNITED STATES ENOXAPARIN SODIUM INJECTION USP 40MG/0.4MLENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGESROSINOX-40 USP | $20.9M | 5 | 10.0% |
| 4 | FRESENIUS KABI USA LLCUNITED STATES ENOXAPARIN SODIUM INJECTION USP 40MG/0.4MLENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGES51000441 - ENOXAPARIN SODIUM INJECTION, | $12.0M | 5 | 5.7% |
| 5 | EVERSANAUNITED STATES ENOXAPARIN SODIUM INJECTION USP 40MG/0.4MLENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGES | $7.2M | 5 | 3.4% |
| 6 | FRESENIUS KABI USA LLC,UNITED STATES ENOXAPARIN SODIUM INJECTION USP 40MG/0.4MLENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGES51000441 - ENOXAPARIN SODIUM INJECTION, | $4.8M | 5 | 2.3% |
| 7 | EVERSANA LIFE SCIENCE SERVICES LLCUNITED STATES ENOXAPARIN SODIUM INJECTION USP 40MG/0.4MLENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGES | $4.8M | 5 | 2.3% |
| 8 | FRESENIUS KABI CANADA LTDCANADA ENOXAPARIN SODIUM INJECTION USP 40MG/0.4MLENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGES51000441 - ENOXAPARIN SODIUM INJECTION, | $4.7M | 5 | 2.3% |
| 9 | STATE PHARMACEUTICALS CORPORATIONSRI LANKA LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINENOXAPARIN SODIUM USP 40MG/0.4ML INJECTI | $4.4M | 5 | 2.1% |
| 10 | EVERSANA EVERSANAUNITED STATES ENOXAPARIN SODIUM INJECTION USP 40MG/0.4MLENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGES | $3.6M | 5 | 1.7% |
| 11 | PHARMACEUTICAL TECHNOLOGYDOMINICAN REPUBLIC ENOXAPARIN SODIUM INJECTION USP 40MG/0.4MLENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGESLOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN | $2.3M | 5 | 1.1% |
| 12 | LABORATORIOS VANQUISH SA DE CVMEXICO ENOXAPARIN INJECTION IP 60MG/0.6 ML51000843 - ENOXAPARIN SODIUM INJECTION USP, 40 MG/0.4 MLENOXAPARIN INJECTION IP 80MG/0.8 ML | $1.9M | 5 | 0.9% |
| 13 | NORDIC PHARMACEUTICAL COMPANY SACPERU | $1.5M | 5 | 0.7% |
| 14 | PEOPLE'S BANKSRI LANKA LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINENOXAPARIN SODIUM USP 40MG/0.4ML INJECTI | $1.3M | 5 | 0.6% |
| 15 | BOSTON ONCOLOGY ARABIA NASAUDI ARABIA LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN | $1.2M | 5 | 0.6% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Enoxaparin — and from which countries?
Flow of Enoxaparin exports from India: each country's share and the named importers behind the numbers
Enoxaparin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $102.7M through 744 shipments. This represents a market share of 49.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• FRESENIUS KABI USA, LLC - $48.6M (47.3% of country's total business)
• BE PHARMACEUTICALS INC - $20.9M (20.3% of country's total business)
• FRESENIUS KABI USA LLC - $12.0M (11.7% of country's total business)
• EVERSANA - $7.2M (7.0% of country's total business)
• FRESENIUS KABI USA LLC, - $4.8M (4.7% of country's total business)
• Rest of United States's importers - $9.2M (8.9% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $138.0K, indicating premium pricing strategy compared to the market average of $63.3K.
United States is a key market for Enoxaparin imports, representing 49.0% of total trade value.
2Saudi Arabia
Saudi Arabia emerges as the second largest importing country, achieving a total trade value of $46.1M through 259 shipments. This represents a market share of 22.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Saudi Arabia has a diverse importer base, with their top importers including:
• BOSTON ONCOLOGY ARABIA - $44.5M (96.6% of country's total business)
• BOSTON ONCOLOGY ARABIA NA - $1.2M (2.7% of country's total business)
Key Insight: Saudi Arabia demonstrates strong market positioning with an average shipment value of $178.1K, indicating premium pricing strategy compared to the market average of $63.3K.
Saudi Arabia is a key market for Enoxaparin imports, representing 22.0% of total trade value.
3Sri Lanka
Sri Lanka emerges as the third largest importing country, achieving a total trade value of $7.9M through 11 shipments. This represents a market share of 3.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Sri Lanka has a diverse importer base, with their top importers including:
• STATE PHARMACEUTICALS CORPORATION - $4.4M (56.0% of country's total business)
• PEOPLE'S BANK - $1.3M (17.1% of country's total business)
Key Insight: Sri Lanka demonstrates strong market positioning with an average shipment value of $714.9K, indicating premium pricing strategy compared to the market average of $63.3K.
Sri Lanka is a key market for Enoxaparin imports, representing 3.8% of total trade value.
4Canada
Canada emerges as the fourth largest importing country, achieving a total trade value of $5.2M through 87 shipments. This represents a market share of 2.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• FRESENIUS KABI CANADA LTD - $4.7M (90.7% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $59.8K, indicating competitive pricing strategy compared to the market average of $63.3K.
Canada is a key market for Enoxaparin imports, representing 2.5% of total trade value.
5Dominican Republic
Dominican Republic emerges as the fifth largest importing country, achieving a total trade value of $3.4M through 52 shipments. This represents a market share of 1.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Dominican Republic has a diverse importer base, with their top importers including:
• PHARMACEUTICAL TECHNOLOGY - $2.3M (65.4% of country's total business)
Key Insight: Dominican Republic demonstrates strong market positioning with an average shipment value of $66.3K, indicating premium pricing strategy compared to the market average of $63.3K.
Dominican Republic is a key market for Enoxaparin imports, representing 1.6% of total trade value.
Buyer Segment Analysis
TransData Nexus Enoxaparin buyer market intelligence
1Buyer Segment Analysis
The 505 buyers of Enoxaparin imported from India can be categorized into several segments:
1. Distributors: Entities like EVERSANA and BE PHARMACEUTICALS INC in the United States fall into this category. They purchase Enoxaparin in bulk and distribute it to various healthcare providers, pharmacies, and hospitals. Their buying behavior typically involves large-volume orders to ensure a steady supply chain and meet the demands of their clients.
2. Hospital Groups: While specific hospital groups are not listed among the top 10 buyers, such entities procure Enoxaparin directly to administer to patients within their facilities. Their purchasing patterns are driven by patient needs and treatment protocols, often resulting in consistent, moderate-sized orders.
3. Government Procurement Agencies: The State Pharmaceuticals Corporation in Sri Lanka exemplifies this segment. Such agencies procure medications like Enoxaparin through national tenders to supply public healthcare institutions. Their buying behavior is characterized by large-scale, periodic purchases aligned with government healthcare programs and budgets.
4. Re-exporters: Entities that purchase Enoxaparin for the purpose of exporting to other countries. Their order patterns depend on the demand in their target markets and international trade agreements.
5. Contract Manufacturers: Companies that procure Enoxaparin as an active pharmaceutical ingredient (API) to produce finished dosage forms for other brands or markets. Their purchasing behavior is influenced by manufacturing schedules and contractual obligations.
Understanding these segments and their purchasing behaviors is crucial for suppliers aiming to tailor their strategies to meet the specific needs of each buyer type.
Country-Specific Import Regulations
TransData Nexus Enoxaparin buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Enoxaparin from India, the import regulations are as follows:
1. United States:
2. Saudi Arabia:
3. Sri Lanka:
4. Canada:
5. Dominican Republic:
Navigating these regulatory landscapes requires thorough preparation and compliance with each country's specific requirements to ensure successful market entry.
Demand Drivers & Market Opportunity
TransData Nexus Enoxaparin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Enoxaparin in importing countries is driven by several key factors:
1. Disease Prevalence: Enoxaparin is primarily used for the prevention and treatment of thromboembolic disorders, which are prevalent globally. Conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE) contribute significantly to the demand for anticoagulant therapies.
2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the World Health Organization (WHO) emphasizes the importance of essential medicines in healthcare systems, advocating for their availability and affordability. (iris.who.int)
3. Universal Health Coverage Expansion: The global push towards universal health coverage has led to increased procurement of essential medicines like Enoxaparin. Countries are striving to ensure that all individuals have access to necessary healthcare services, including medications.
4. WHO Essential Medicines List Procurement: Enoxaparin's inclusion in the WHO Essential Medicines List underscores its importance in treating thromboembolic conditions. This inclusion often influences national procurement decisions, leading to increased demand.
5. Tender-Based Purchasing: Many governments and healthcare institutions procure medicines through tender processes to ensure cost-effectiveness and quality. Enoxaparin is frequently included in such tenders, reflecting its critical role in healthcare.
With 505 buyers across 118 countries, the market for Enoxaparin presents substantial opportunities. Suppliers can leverage these demand drivers by aligning their strategies with national healthcare priorities and participating in tender processes to expand their market presence.
Common Questions — Enoxaparin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest enoxaparin buyer importing from India?
Based on import volume and value, FRESENIUS KABI USA, LLC (UNITED STATES) leads with $48.6M in imports and a 23.2% market share — the highest of any single enoxaparin importer. BOSTON ONCOLOGY ARABIA (SAUDI ARABIA) and BE PHARMACEUTICALS INC (UNITED STATES) are the next largest buyers.
QHow many companies buy enoxaparin from India?
There are 505 active enoxaparin buyers importing from India, with a combined market of $209.4M across 3,309 shipments to 118 countries. The top 5 buyers hold 63.6% of total import value, while the remaining 500 buyers handle the other 36.4%.
QWhich countries import the most enoxaparin from India?
The top importing countries for enoxaparin from India are United States (49.0%), Saudi Arabia (22.0%), Sri Lanka (3.8%), Canada (2.5%), Dominican Republic (1.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of enoxaparin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for enoxaparin from India?
The average import transaction value for enoxaparin from India is $63.3K, with an average unit price of $105.76 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Enoxaparin buyer market intelligence
1Buyer Segment Analysis
The 505 buyers of Enoxaparin imported from India can be categorized into several segments:
1. Distributors: Entities like EVERSANA and BE PHARMACEUTICALS INC in the United States fall into this category. They purchase Enoxaparin in bulk and distribute it to various healthcare providers, pharmacies, and hospitals. Their buying behavior typically involves large-volume orders to ensure a steady supply chain and meet the demands of their clients.
2. Hospital Groups: While specific hospital groups are not listed among the top 10 buyers, such entities procure Enoxaparin directly to administer to patients within their facilities. Their purchasing patterns are driven by patient needs and treatment protocols, often resulting in consistent, moderate-sized orders.
3. Government Procurement Agencies: The State Pharmaceuticals Corporation in Sri Lanka exemplifies this segment. Such agencies procure medications like Enoxaparin through national tenders to supply public healthcare institutions. Their buying behavior is characterized by large-scale, periodic purchases aligned with government healthcare programs and budgets.
4. Re-exporters: Entities that purchase Enoxaparin for the purpose of exporting to other countries. Their order patterns depend on the demand in their target markets and international trade agreements.
5. Contract Manufacturers: Companies that procure Enoxaparin as an active pharmaceutical ingredient (API) to produce finished dosage forms for other brands or markets. Their purchasing behavior is influenced by manufacturing schedules and contractual obligations.
Understanding these segments and their purchasing behaviors is crucial for suppliers aiming to tailor their strategies to meet the specific needs of each buyer type.
Country-Specific Import Regulations
TransData Nexus Enoxaparin buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Enoxaparin from India, the import regulations are as follows:
1. United States:
2. Saudi Arabia:
3. Sri Lanka:
4. Canada:
5. Dominican Republic:
Navigating these regulatory landscapes requires thorough preparation and compliance with each country's specific requirements to ensure successful market entry.
Demand Drivers & Market Opportunity
TransData Nexus Enoxaparin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Enoxaparin in importing countries is driven by several key factors:
1. Disease Prevalence: Enoxaparin is primarily used for the prevention and treatment of thromboembolic disorders, which are prevalent globally. Conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE) contribute significantly to the demand for anticoagulant therapies.
2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the World Health Organization (WHO) emphasizes the importance of essential medicines in healthcare systems, advocating for their availability and affordability. (iris.who.int)
3. Universal Health Coverage Expansion: The global push towards universal health coverage has led to increased procurement of essential medicines like Enoxaparin. Countries are striving to ensure that all individuals have access to necessary healthcare services, including medications.
4. WHO Essential Medicines List Procurement: Enoxaparin's inclusion in the WHO Essential Medicines List underscores its importance in treating thromboembolic conditions. This inclusion often influences national procurement decisions, leading to increased demand.
5. Tender-Based Purchasing: Many governments and healthcare institutions procure medicines through tender processes to ensure cost-effectiveness and quality. Enoxaparin is frequently included in such tenders, reflecting its critical role in healthcare.
With 505 buyers across 118 countries, the market for Enoxaparin presents substantial opportunities. Suppliers can leverage these demand drivers by aligning their strategies with national healthcare priorities and participating in tender processes to expand their market presence.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 505 global importers of Enoxaparin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,309 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 118 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,309 Verified Shipments
505 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists